Medifast Stock News

BALTIMORE, Feb. 11, 2022 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, will announce financial results for the fourth quarter and full year ended December 31, 2021 on Wednesday, February 23,…

BALTIMORE, Feb. 11, 2022 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, will announce financial results f

MEDIFAST INC found using ticker (MED) now have 3 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 350 and 345 with the average target price sitting at 348. With the stocks previous close at 196.12 this is indicating there is a potential upside of 77.4%. The 50 day moving average now sits at 202.75 and the 200 day MA is 236.59. The company has a market capitalisation of $2,242m. You can visit the company''s website by visiting: https://medifastinc.com [stock_market_widget type="chart" symbol="MED" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] The potential market cap would be $3,979m based on the market concensus. Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands.

Medifast (MED) could produce exceptional returns because of its solid growth attributes.

Medifast Inc (MED) shares closed today at 0.6% above its 52 week low of $184.48, giving the company a market cap of $2B. The stock is currently down 6.9% year-to-date, down 16.4% over the past 12 months, and up 430.2% over the past five years. This week, the Dow Jones Industrial Average rose 4.3%, and the S&P 500 rose 5.5%. Trading Activity Trading volume this week was 10.6% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Communication Services industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -67.6% The company's stock price performance over the past 12 months beats the peer average by -66.6% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 110.1% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Want to try a different approach? Tap five stocks with increasing P/E ratios such as MEDIFAST (MED), JAKKS Pacific (JAKK), Asbury Automotive Group (ABG), Zymeworks (ZYME) and Polaris (PII).

Medifast (MED) has been benefiting from the strength of its OPTAVIA lifestyle solution and coaching support system, as well as efficient technological investments.

9m'21 revenues growing by 70% compared to previous year.

Medifast (MED) possesses solid growth attributes, which could help it handily outperform the market.

Medifast (MED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

BALTIMORE, Dec. 29, 2021 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced today that Dan Chard, C

Medifast (MED) has been gaining on strength of its OPTAVIA lifestyle solution and coaching support system, which was a major driver in the third quarter.

WINTON GROUP Ltd grew its stake in shares of Medifast, Inc. (NYSE:MED) by 1.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,683 shares of the specialty retailers stock after purchasing an additional 74 shares during the quarter. WINTON GROUP Ltds holdings []